Can-Fite BioPharma Ltd.
CANF
$3.39
$0.030.89%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.54M | 8.54M | 6.46M | 6.46M | 7.89M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 826.00K | 826.00K | 1.17M | 1.17M | 1.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 74.00K | 74.00K | -- | -- | 77.00K |
| Total Current Assets | 9.44M | 9.44M | 7.62M | 7.62M | 8.98M |
|
|
|||||
| Total Current Assets | 9.44M | 9.44M | 7.62M | 7.62M | 8.98M |
| Net Property, Plant & Equipment | 74.00K | 74.00K | 96.00K | 96.00K | 138.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.51M | 9.51M | 7.72M | 7.72M | 9.12M |
|
|
|||||
| Total Accounts Payable | 1.16M | 1.16M | 1.15M | 1.15M | 618.00K |
| Total Accrued Expenses | 1.11M | 1.11M | 506.00K | 506.00K | 976.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 56.00K | 56.00K | 57.00K | 57.00K | 53.00K |
| Total Finance Division Other Current Liabilities | 405.00K | 405.00K | 405.00K | 405.00K | 405.00K |
| Total Other Current Liabilities | 405.00K | 405.00K | 405.00K | 405.00K | 405.00K |
| Total Current Liabilities | 2.73M | 2.73M | 2.12M | 2.12M | 2.05M |
|
|
|||||
| Total Current Liabilities | 2.73M | 2.73M | 2.12M | 2.12M | 2.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.00K | 15.00K | 33.00K | 33.00K | 51.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.18M | 1.18M | 1.38M | 1.38M | 1.58M |
| Total Liabilities | 3.92M | 3.92M | 3.54M | 3.54M | 3.68M |
|
|
|||||
| Common Stock & APIC | 180.65M | 180.65M | 174.29M | 174.29M | 170.67M |
| Retained Earnings | -176.19M | -176.19M | -171.24M | -171.24M | -166.36M |
| Treasury Stock & Other | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
| Total Common Equity | 5.59M | 5.59M | 4.18M | 4.18M | 5.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.59M | 5.59M | 4.18M | 4.18M | 5.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.59M | 5.59M | 4.18M | 4.18M | 5.44M |
|
|
|||||